Ginsenosides protect striatal neurons in a cellular model of Huntington's disease

Jun Wu, Hye Kyoung Jeong, Sarah Elizabeth Bulin, Sung Won Kwon, Jeong Hill Park, Ilya Bezprozvanny

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), is a widely used herbal medicine. Ginsenosides, the active ingredients of ginseng, are the main components responsible for many beneficial actions of ginseng. In the present study, we tested 10 different ginsenosides in the previously developed in vitro Huntington's disease (HD) assay with primary medium spiny striatal neuronal cultures (MSN) from the YAC128 HD mouse model. We found that nanomolar concentrations of ginsenoside Rb1 and Rc effectively protected YAC128 medium spiny neurons from glutamate-induced apoptosis and that Rg5 was protective at micromolar concentration. The other seven ginsenosides tested were not effective or exerted toxic effects in MSN cultures. From further experiments, we suggested that neuroprotective effects of ginsenosides Rb1, Rc, and Rg5 could correlate with their ability to inhibit glutamate-induced Ca2+ responses in cultured MSN. From these results we concluded that ginsenosides Rb1, Rc, and Rg5 offer a potential therapeutic choice for the treatment of HD and possibly other neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)1904-1912
Number of pages9
JournalJournal of Neuroscience Research
Volume87
Issue number8
DOIs
StatePublished - 2009

Fingerprint

Ginsenosides
Corpus Striatum
Panax
Huntington Disease
Neurons
Glutamic Acid
Araliaceae
Aptitude
Herbal Medicine
Poisons
Neuroprotective Agents
Neurodegenerative Diseases
Apoptosis
Therapeutics
ginsenoside Rc
ginsenoside Rb1
ginsenoside Rg5

Keywords

  • Apoptosis
  • Excitotoxicity
  • Ginseng
  • Ginsenosides
  • Huntington's disease
  • Transgenic mouse

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Ginsenosides protect striatal neurons in a cellular model of Huntington's disease. / Wu, Jun; Jeong, Hye Kyoung; Bulin, Sarah Elizabeth; Kwon, Sung Won; Park, Jeong Hill; Bezprozvanny, Ilya.

In: Journal of Neuroscience Research, Vol. 87, No. 8, 2009, p. 1904-1912.

Research output: Contribution to journalArticle

Wu, Jun ; Jeong, Hye Kyoung ; Bulin, Sarah Elizabeth ; Kwon, Sung Won ; Park, Jeong Hill ; Bezprozvanny, Ilya. / Ginsenosides protect striatal neurons in a cellular model of Huntington's disease. In: Journal of Neuroscience Research. 2009 ; Vol. 87, No. 8. pp. 1904-1912.
@article{9c9d948c33904457a8e3f8aaba8b912c,
title = "Ginsenosides protect striatal neurons in a cellular model of Huntington's disease",
abstract = "Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), is a widely used herbal medicine. Ginsenosides, the active ingredients of ginseng, are the main components responsible for many beneficial actions of ginseng. In the present study, we tested 10 different ginsenosides in the previously developed in vitro Huntington's disease (HD) assay with primary medium spiny striatal neuronal cultures (MSN) from the YAC128 HD mouse model. We found that nanomolar concentrations of ginsenoside Rb1 and Rc effectively protected YAC128 medium spiny neurons from glutamate-induced apoptosis and that Rg5 was protective at micromolar concentration. The other seven ginsenosides tested were not effective or exerted toxic effects in MSN cultures. From further experiments, we suggested that neuroprotective effects of ginsenosides Rb1, Rc, and Rg5 could correlate with their ability to inhibit glutamate-induced Ca2+ responses in cultured MSN. From these results we concluded that ginsenosides Rb1, Rc, and Rg5 offer a potential therapeutic choice for the treatment of HD and possibly other neurodegenerative disorders.",
keywords = "Apoptosis, Excitotoxicity, Ginseng, Ginsenosides, Huntington's disease, Transgenic mouse",
author = "Jun Wu and Jeong, {Hye Kyoung} and Bulin, {Sarah Elizabeth} and Kwon, {Sung Won} and Park, {Jeong Hill} and Ilya Bezprozvanny",
year = "2009",
doi = "10.1002/jnr.22017",
language = "English (US)",
volume = "87",
pages = "1904--1912",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Ginsenosides protect striatal neurons in a cellular model of Huntington's disease

AU - Wu, Jun

AU - Jeong, Hye Kyoung

AU - Bulin, Sarah Elizabeth

AU - Kwon, Sung Won

AU - Park, Jeong Hill

AU - Bezprozvanny, Ilya

PY - 2009

Y1 - 2009

N2 - Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), is a widely used herbal medicine. Ginsenosides, the active ingredients of ginseng, are the main components responsible for many beneficial actions of ginseng. In the present study, we tested 10 different ginsenosides in the previously developed in vitro Huntington's disease (HD) assay with primary medium spiny striatal neuronal cultures (MSN) from the YAC128 HD mouse model. We found that nanomolar concentrations of ginsenoside Rb1 and Rc effectively protected YAC128 medium spiny neurons from glutamate-induced apoptosis and that Rg5 was protective at micromolar concentration. The other seven ginsenosides tested were not effective or exerted toxic effects in MSN cultures. From further experiments, we suggested that neuroprotective effects of ginsenosides Rb1, Rc, and Rg5 could correlate with their ability to inhibit glutamate-induced Ca2+ responses in cultured MSN. From these results we concluded that ginsenosides Rb1, Rc, and Rg5 offer a potential therapeutic choice for the treatment of HD and possibly other neurodegenerative disorders.

AB - Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), is a widely used herbal medicine. Ginsenosides, the active ingredients of ginseng, are the main components responsible for many beneficial actions of ginseng. In the present study, we tested 10 different ginsenosides in the previously developed in vitro Huntington's disease (HD) assay with primary medium spiny striatal neuronal cultures (MSN) from the YAC128 HD mouse model. We found that nanomolar concentrations of ginsenoside Rb1 and Rc effectively protected YAC128 medium spiny neurons from glutamate-induced apoptosis and that Rg5 was protective at micromolar concentration. The other seven ginsenosides tested were not effective or exerted toxic effects in MSN cultures. From further experiments, we suggested that neuroprotective effects of ginsenosides Rb1, Rc, and Rg5 could correlate with their ability to inhibit glutamate-induced Ca2+ responses in cultured MSN. From these results we concluded that ginsenosides Rb1, Rc, and Rg5 offer a potential therapeutic choice for the treatment of HD and possibly other neurodegenerative disorders.

KW - Apoptosis

KW - Excitotoxicity

KW - Ginseng

KW - Ginsenosides

KW - Huntington's disease

KW - Transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=66049095622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049095622&partnerID=8YFLogxK

U2 - 10.1002/jnr.22017

DO - 10.1002/jnr.22017

M3 - Article

C2 - 19185022

AN - SCOPUS:66049095622

VL - 87

SP - 1904

EP - 1912

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 8

ER -